You asked your insurance company to cover GLP-1 medication and they said no. That's frustrating — but it's not the end of the road. Insurance denials can be appealed, and a significant percentage of appeals succeed, particularly when the appeal is well-documented and submitted correctly.
This guide walks you through the process step by step.
Why Insurance Companies Deny GLP-1 Coverage
The most common denial reasons:
- Not medically necessary: The insurer's clinical criteria weren't met — usually a BMI threshold or comorbidity requirement
- Step therapy required: Your plan requires you to try and fail on a cheaper medication (like phentermine or Contrave) before approving a GLP-1
- Prior authorization not submitted: Your doctor didn't complete the paperwork before prescribing
- Formulary exclusion: The specific medication isn't on your plan's covered drug list
- Off-label use: The medication was prescribed for weight loss but your plan only covers it for diabetes
Step 1: Get the Denial in Writing
Request the written denial letter from your insurer. By law (under the ACA and ERISA for employer plans), they must provide a written explanation that includes the specific reason for denial, the clinical criteria they used, and instructions for how to appeal. This letter is your roadmap — your appeal needs to directly address the stated reason for denial.
Step 2: Internal Appeal (First Level)
Every insurance plan must offer at least one level of internal appeal. You typically have 180 days from the denial to file, though some plans have shorter windows — check your denial letter for the exact deadline.
What Your Appeal Should Include
- A letter from your doctor explaining why the medication is medically necessary for your specific condition. This is the single most important document in your appeal.
- Clinical documentation: BMI records, lab results showing comorbidities (A1c, lipid panel, blood pressure), weight history showing failed diet attempts
- Relevant clinical guidelines: The Endocrine Society, American Association of Clinical Endocrinology (AACE), and AMA all have published guidelines supporting GLP-1 use for obesity treatment. Reference these.
- Documentation of failed alternatives: If step therapy was the denial reason, provide records of medications you've already tried — even if they were prescribed by a different doctor years ago
"I am writing to appeal the denial of [medication name] for [patient name]. The patient has a BMI of [X], with the following comorbidities: [list]. The patient has previously attempted [list failed interventions] without sustained success. Per the Endocrine Society Clinical Practice Guidelines and AACE Obesity Clinical Practice Guidelines, GLP-1 receptor agonist therapy is indicated for patients meeting these criteria. I believe this medication is medically necessary for this patient's chronic disease management."
Step 3: External Review (If Internal Appeal Fails)
If your internal appeal is denied, you have the right to an external review by an independent third party — someone not employed by your insurance company. This is a federal right under the ACA for most plans.
External reviews are decided by independent physicians who review your medical records against current clinical evidence. The success rate for external reviews is often higher than internal appeals because the reviewers are not financially motivated to deny coverage.
You typically have 4 months from the internal appeal denial to request external review. The review must be completed within 45 days (72 hours for urgent/expedited requests).
Step 4: If Both Appeals Fail
If both internal and external appeals are denied, you still have options:
- File a complaint with your state insurance commissioner: State regulators can investigate whether the denial was appropriate under your plan's terms
- Request a peer-to-peer review: Ask your doctor to speak directly with the insurer's medical director. Sometimes a live conversation resolves what paperwork couldn't.
- Switch plans at open enrollment: If your current plan categorically excludes weight loss medications, switching to a plan that covers them may be the path of least resistance
- Consider cash-pay alternatives: Compounded GLP-1 medications through telehealth providers are a fraction of brand-name cost and bypass insurance entirely
Affordable Cash-Pay Alternatives
Paid links · Compounded medications are not FDA-approved.
Timelines That Matter
- Internal appeal deadline: Usually 180 days from denial (check your letter)
- Internal appeal decision: 30 days for pre-service; 60 days for post-service
- External review request: 4 months from internal denial
- External review decision: 45 days (72 hours for urgent cases)
Don't let deadlines lapse. A missed deadline can forfeit your appeal rights entirely.